We are live on ! Find out more
CCM

Catapult Capital Management Portfolio holdings

AUM $265M
1-Year Est. Return 21.83%
This Fund
S&P 500
This Quarter Est. Return
+5.74%
1 Year Est. Return
+21.83%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$696M
AUM Growth
-$122M
Cap. Flow
-$135M
Cap. Flow %
-19.45%
Top 10 Hldgs %
23.76%
Holding
329
New
119
Increased
34
Reduced
64
Closed
111

Top Buys

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$23.2M
2
PEP icon
PepsiCo
PEP
+$13.1M
3
ABBV icon
AbbVie
ABBV
+$10.1M
4
ELV icon
Elevance Health
ELV
+$9.59M
5
ABT icon
Abbott
ABT
+$8.4M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$22.4M
2
PFE icon
Pfizer
PFE
+$18M
3
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$13.1M
4
MD icon
Pediatrix Medical
MD
+$11.2M
5
DHR icon
Danaher
DHR
+$11.1M

Sector Composition

Rank Sector Weight
1 Healthcare 42.68%
2 Consumer Discretionary 8.46%
3 Industrials 7.26%
4 Consumer Staples 5.08%
5 Communication Services 3.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCI icon
51
Crown Castle
CCI
$33.4B
$3.77M 0.54%
+47,009
New +$3.92M
LVLT
52
DELISTED
Level 3 Communications Inc
LVLT
$3.73M 0.54%
+70,730
New +$3.88M
MGA icon
53
Magna International
MGA
$19B
$3.71M 0.53%
66,167
-15,685
-19% -$873K
BCC icon
54
CALL
Boise Cascade
BCC
$2.65B
$3.67M 0.53%
+100,000
New +$3.66M
SIG icon
55
Signet Jewelers
SIG
$3.72B
$3.67M 0.53%
28,580
+2,507
+10% +$336K
XYL icon
56
Xylem
XYL
$27.3B
$3.66M 0.53%
+98,637
New +$3.59M
AMZN icon
57
Amazon
AMZN
$2.53T
$3.63M 0.52%
167,440
-21,820
-12% -$456K
IQV icon
58
IQVIA
IQV
$39.1B
$3.63M 0.52%
+50,000
New +$3.43M
WY icon
59
Weyerhaeuser
WY
$16.9B
$3.51M 0.5%
+111,339
New +$3.58M
DYN
60
DELISTED
Dynegy, Inc.
DYN
$3.5M 0.5%
119,663
-174,981
-59% -$5.69M
SPXC icon
61
SPX Corp
SPXC
$9.98B
$3.5M 0.5%
191,823
+109,476
+133% +$2.14M
TMUS icon
62
T-Mobile US
TMUS
$186B
$3.48M 0.5%
89,796
-49,068
-35% -$1.76M
HZNP
63
PUT
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.47M 0.5%
+100,000
New +$3.05M
HCA icon
64
HCA Healthcare
HCA
$85.7B
$3.45M 0.5%
38,036
-11,964
-24% -$959K
TMX
65
DELISTED
Terminix Global Holdings, Inc.
TMX
$3.39M 0.49%
+139,969
New +$3.25M
CSC
66
CALL
DELISTED
Computer Sciences
CSC
$3.28M 0.47%
+118,650
New +$3.32M
BIO icon
67
Bio-Rad Laboratories Class A
BIO
$8.74B
$3.25M 0.47%
21,574
-15,608
-42% -$2.23M
DXCM icon
68
DexCom
DXCM
$28.8B
$3.2M 0.46%
160,000
+120,000
+300% +$2.11M
CCRN
69
DELISTED
Cross Country Healthcare
CCRN
$3.17M 0.46%
250,000
+39,220
+19% +$445K
ACHC icon
70
Acadia Healthcare
ACHC
$2.62B
$3.13M 0.45%
+40,000
New +$2.88M
APC
71
CALL
DELISTED
Anadarko Petroleum
APC
$3.12M 0.45%
+40,000
New +$3.46M
BRCM
72
DELISTED
BROADCOM CORP CL-A
BRCM
$3.12M 0.45%
+60,507
New +$2.95M
HMHC
73
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$3.08M 0.44%
+122,229
New +$3.03M
AGN
74
DELISTED
Allergan plc
AGN
$3.04M 0.44%
10,000
-10,000
-50% -$2.98M
TIF
75
DELISTED
Tiffany & Co.
TIF
$3.01M 0.43%
32,770
+24,433
+293% +$2.19M
1 2
3
4 5

Similar funds

LOCB
Lombard Odier & Cie (Bahamas) Nassau, Bahamas $263M AUM 3.37% 1-Year Est. Return
AF
Adirondack Funds Guilderland, New York $261M AUM
TCOTO
Trust Company of the Ozarks Springfield, Missouri $290M AUM 12.7% 1-Year Est. Return
DCM
Dinsmore Capital Management Morristown, New Jersey $230M AUM 0.29% 1-Year Est. Return
SCA
Samson Capital Advisors New York $228M AUM 0.84% 1-Year Est. Return
LPVHS
Lexington Partners VI Holdings Sub New York $227M AUM 24.75% 1-Year Est. Return
ATC
Argent Trust Company Ruston, Louisiana $225M AUM 5.44% 1-Year Est. Return
TFF
Timothy F. Fidgeon $203M AUM 2.36% 1-Year Est. Return

Catapult Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, Catapult Capital Management held 329 positions worth $696M, down 15% from $818M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Catapult Capital Management withdrew a net $135M in Q2 2015, closing 111 positions and reducing 64 holdings. Its most notable exit was Pfizer, an estimated $18M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Catapult Capital Management opened a new position in Zoetis worth $23.5M.

  • Catapult Capital Management's largest Q2 2015 buy was Zoetis: 486,665 shares worth $23.5M.
  • Catapult Capital Management added most to AbbVie in Q2 2015, an estimated $10.1M increase.
  • Catapult Capital Management's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $22.4M.
  • Catapult Capital Management fully exited Pfizer in Q2 2015, selling an estimated $18M.
  • Catapult Capital Management's ten largest holdings make up 24% of its $696M portfolio in Q2 2015.
  • Catapult Capital Management opened 119 new positions and closed 111 in Q2 2015.
  • Catapult Capital Management's portfolio value fell 15% quarter-over-quarter to $696M.

Based on Catapult Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.